Dr. Burton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1960 N Ogden St
Ste 400
Denver, CO 80218Phone+1 303-318-1585
Summary
- Dr. Christine Burton grew up in Littleton, Colorado. She attended Brigham Young University and graduated with a Bachelor of Science in Physiology and Developmental Biology. For medical school, she attended University of Colorado School of Medicine. She remained in Denver for her general surgical residency training at St. Joseph's Hospital, an inner-city community program.
Christine is now applying for further training in endocrine and head and neck surgery. Her career goals include offering specialized surgical care to those with head and neck cancer including thyroid cancer, parathyroid adenoma, salivary gland tumors, oral-pharyngeal cancer, and head and neck melanoma.
Education & Training
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2019
- Brigham Young UniversityBachelor of Science, Physiology and Developmental Biology, 2011 - 2015
Certifications & Licensure
- NY State Medical License 2024 - 2026
- CO State Medical License 2020 - 2025
Awards, Honors, & Recognition
- George Packard Award for Outstanding Performance in Surgery University of Colorado School of Medicine, 2015
Publications & Presentations
Abstracts/Posters
- Potential benefits and challenges of incorporating near infrared autofluorescence imaging into endocrine surgical practiceBurton C.R., Vanderveen K., Davis-Merritt D., Southwest Surgical Congress, Ojai, CA, 4/2022
- Using adenoma weight and volume to predict multi-gland disease in primary hyperparathyroidismLee, J. , Albuja-Cruz, M. B., Burton, C. R., Raeburn, C.D., McIntryre, R., Academic Surgical Congress, Las Vegas, NV, 5/2017
- Thymidine Kinase I as a possible therapeutic agent in Burkitt's lymphomaBurton C.R., American Association for Cancer Research, Washington, DC, 4/2013
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: